Haemonetics plans to buy Quebec City-based sensor company OpSens for about $253m by the end of January 2024. The deal, announced on 10 October, will expand OpSens presence in high-growth internatio
The global market for diagnostic and guided interventional cardiology products is forecast to grow from $3.5bn in 2016 to $4.8bn by 2021, at a compound annual growth rate (CAGR) of 6.4%. (See Figure 1